GSK Asks China's Hengrui To Develop 12 Drugs For $12B
Pharmaceutical giant GSK said Monday that it will pay up to $12 billion for Hengrui Pharma of China to develop up to 12 medicines to add to its respiratory, immunology and...To view the full article, register now.
Already a subscriber? Click here to view full article